Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-2 of 2
Keywords: Antidiabetics
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
The Impact of Diabetes and Antidiabetics on Uro-Oncological Disease Outcomes: A Single-Center Experience
Open AccessSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2025) 109 (4): 361–371.
Published Online: 24 January 2025
...Moustafa Elleisy; Heike Zettl; Desiree Louise Dräger; Oliver W. Hakenberg Introduction: The aim of this study was to determine the impact of diabetes and antidiabetic medications on referral and pathological outcomes in uro-oncology cases. We report preliminary results from a single-center study...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2025) 109 (3): 311–312.
Published Online: 16 December 2024
... Antidiabetics Dear Editor, With this letter, we aim to initiate a broader discussion about the impact of diabetes and antidiabetic medications on the so-called obesity paradox in renal cell carcinoma (RCC). RCC accounts for 3% of all cancer cases, and in Europe, 54,054 deaths were reported in 2020...
